Admission Hyperglycemia in Setting of Acute Heart Failure is Associated with Increased In-hospital Mortality Among Patients without Diabetes by Maselli, Nicholas J. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Senior Scholars Program School of Medicine 
2012-05-02 
Admission Hyperglycemia in Setting of Acute Heart Failure is 
Associated with Increased In-hospital Mortality Among Patients 
without Diabetes 
Nicholas J. Maselli 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/ssp 
 Part of the Cardiovascular Diseases Commons, Endocrine System Diseases Commons, Health 
Services Research Commons, and the Life Sciences Commons 
Repository Citation 
Maselli, Nicholas J.; Darling, Chad E.; McManus, David D.; Lessard, Darleen M.; Goldberg, Robert J.; and 
Saczynski, Jane S., "Admission Hyperglycemia in Setting of Acute Heart Failure is Associated with 
Increased In-hospital Mortality Among Patients without Diabetes" (2012). University of Massachusetts 
Medical School. Senior Scholars Program. Paper 124. 
https://escholarship.umassmed.edu/ssp/124 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Senior Scholars 
Program by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Admission Hyperglycemia in Setting of Acute Heart Failure is Associated  
with Increased In-Hospital Mortality among Patients without Diabetes 
Nicholas Maselli BA1,2,4, Chad Darling MD3, David McManus MD1,2,4, Darleen Lessard MS2, Robert J. Goldberg PhD2,4, Jane Saczynski PhD1,2,4 
Departments of Medicine1, Quantititative Health Sciences2, and Emergency Medicine3 and Meyers Primary Care Institute4, University of Massachusetts Medical School, Worcester, MA 
Results Background 
Heart Failure (HF) in the setting 
of comorbid diabetes mellitus 
(DM) has been extensively 
examined and is associated with 
increased mortality.  More 
recently, hyperglycemia 
independent of DM status during 
critical illness admissions has 
become recognized as an 
indicator of poor outcomes.  
Despite evolving understanding 
of DM in the setting of acute HF, 
hyperglycemia at time of 
admission for acute HF has not 
been examined with regard to 
in-hospital treatment and patient 
outcomes. 
Methods 
Worcester Heart Failure Study: 
The sample consisted of 9,748 
residents of the Worcester (MA) 
metropolitan area hospitalized at 
all 11 greater Worcester medical 
centers for acute decompensated 
HF during the years 1995 - 2004 
with data available on diabetic 
status and admission glucose 
measurements.  Patients were 
stratified into three groups based 
on history of DM and admission 
hyperglycemia defined by 
glucose ≥200 mg/dL: 1) 
nondiabetic, normoglycemic 
(NDNG); 2) non-diabetic, 
hyperglycemic (NDHG) and 3) 
Diabetic (DM). 
• The average age of the study sample was 76.2 years, 43.9% were male, and 93.3% were 
Caucasian. 
• Between 1995 and 2004, 56% of patients (n = 5428) were admitted in the NDNG group, 39% of 
patients (n = 3807) were in the DM group, and 5% of patients (n=513) were in the NDHG group. 
• The proportion of hospitalized patients with heart failure in the three glycemic groups remained 
relatively stable over the study period (1995-2004). (Figure 1) 
• Non-diabetic, normoglycemic patients were similar to NDHG patients with respect to age and 
medical history. (Table 1) 
• Non-diabetic, normoglycemic patients were significantly older and less likely to have a history of 
various comorbid conditions such as hypertension, stroke and renal disease when compared to 
diabetics. (Table 1) 
• Diabetics and NDHG patients received significantly more cardiac medications and procedures 
than NDNG patients. (Table 2) 
• Diabetics had significantly more lifestyle recommendations prescribed at discharge than both 
non-diabetic groups. (Table 2) 
• The NDHG group had significantly higher in-hospital mortality than both the NDNG and DM 
groups. (Table 2) 
Conclusions 
The results of our population-based investigation 
demonstrate that non-diabetic patients 
hospitalized for acute HF who are hyperglycemic 
at the time of admission represent a vulnerable 
group of patients at risk for increased mortality 
during hospitalization.  Hyperglycemia ≥200 
mg/dL during acute HF hospitalization should be 
taken into account when providing in-hospital 
management for HF with additional consideration 
given to ascertainment of diabetic status and 
glycemic control. 
a All P-values reflect comparisons to the NDNG group; b Admission serum glucose <200 mg/dL and no history of diabetes; c Admission serum glucose ≥200 mg/dL and no history of diabetes 
* P-value <0.05; **P-value <0.01; ***P-value <0.001 
Table 1. Baseline characteristics according to glycemic statusa 
  NDNGb DM NDHG
c 
Demographics (n = 5428) (n = 3807) (n = 513) 
Age [SD] (mean, years) 78 [13] 74 [11]*** 78 [12] 
Male (%) 44 46 35*** 
Caucasian (%) 94 92*** 95 
Arrived by ambulance (%) 59 62** 75*** 
Medical History (%)   
Heart Failure (HF) 66 79*** 65 
Coronary Heart Disease (CHD) 50 65*** 52 
COPD 36 36 38 
Hypertension 64 75*** 67 
Peripheral Vascular Disease (PVD) 15 27*** 13 
Renal failure/disease 21 34*** 19 
Stroke 12 16*** 11 
Clinical Admission Data   
Systolic BP (mean, mmHg) 140 146*** 154*** 
Diastolic BP (mean, mmHg) 74 74 81*** 
Heart Rate (mean, bpm) 89 88*** 103*** 
BMI (mean, kg/m2) 27 31*** 27 
Cholesterol (mean, mg/dL) 163 162 171 
Serum glucose (mean, mg/dL) 125 197*** 265*** 
Serum creatinine (mean, mg/dL) 1.6 1.8*** 1.5 
Estimated GFR (mean, ml/min/1.73 m) 56 49*** 52*** 
Ejection Fraction (%) 46 45 44* 
Length of hospitalization (mean, days) 6.4 6.0* 7.4 
Table 2. Treatment and outcomes according to glycemic statusa 
  NDNG
b DM NDHG
c 
Medications Received (%) (n = 5428) (n = 3807) (n = 513) 
ACE inhibitor 48 56*** 53 
ARB 6 7* 4 
Aspirin 52 60*** 58** 
β-blocker 53 58*** 58 
Calcium channel blocker 30 36*** 32 
Lipid lowering agent 22 36*** 21 
Digoxin 43 44 45 
Diuretic 97 97 98 
Nitrate 52 64*** 66*** 
Treatment Recommendations (%)   
Low-fat diet 62 66*** 60 
Fluid restriction 14 18*** 14 
Increased physical activity 41 42 48** 
Reduce alcohol intake 1 1 1 
Rehabilitation 11 12 14* 
Salt restriction 76 78* 73 
Smoking cessation 2 2 3 
Procedures Received (%)   
Cardiac catheterization 6  6 7 
PTCA 5 6*** 8***  
CABG 1  1 2** 
Survival (%)   
Discharge 93 94 90* 
Figure 1. Time trends according to glycemic status 
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